These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 10263897)
41. Ohio hospital formularies: an analysis of structure, process, and outcome. Parrish RH; Berger BA Hosp Pharm; 1985 Aug; 20(8):600-3, 606-11. PubMed ID: 10289647 [TBL] [Abstract][Full Text] [Related]
42. Potential and actual drug product selection rates in Florida. Vuturo GJ; McCormick WC; Krischer JP Contemp Pharm Pract; 1980; 3(3):163-70. PubMed ID: 10247872 [TBL] [Abstract][Full Text] [Related]
43. P & T Committee interview: communication and education contribute to an effective formulary system. Hinthorn D; Godwin H Hosp Formul; 1989 May; 24(5):281-4, 286-7. PubMed ID: 10292977 [TBL] [Abstract][Full Text] [Related]
44. [Therapeutic interchange of drugs not included in the hospitaĺs pharmacotherapeutic guide: a quality program]. Navarro de Lara S; Font Noguera I; Lerma Gaude V; López Briz E; Martínez Pascual MJ; Poveda Andrés JL Farm Hosp; 2004; 28(4):266-74. PubMed ID: 15369437 [TBL] [Abstract][Full Text] [Related]
45. Formulary system versus formulary, "the book". Habeger HE Am J Hosp Pharm; 1987 Sep; 44(9):2030. PubMed ID: 3674036 [No Abstract] [Full Text] [Related]
46. Experience with a hospital formulary. Bateson MC; Crooks J; Hamley JG; Leach R; MacConnachie A; Newton RW; Tudhope GR Health Bull (Edinb); 1981 Jan; 39(1):45-50. PubMed ID: 7216759 [No Abstract] [Full Text] [Related]
47. Drug usage guidelines, Part 2: Analysis of program outcome. Patry RA; Huber SL; Hudson HD; Godwin HN Hosp Formul; 1985 Jan; 20(1):57-60. PubMed ID: 10269762 [TBL] [Abstract][Full Text] [Related]
48. Formulary management at a tertiary-care facility: P&T committee interview. Lucas RV; Abramowitz PW Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021 [TBL] [Abstract][Full Text] [Related]
49. State regulatory positions concerning therapeutic substitutions in hospitals. Doering PL; McCormick WC; Klapp DL; Russell WL Am J Hosp Pharm; 1981 Dec; 38(12):1900-3. PubMed ID: 7325169 [TBL] [Abstract][Full Text] [Related]
50. Strengthening the formulary system by implementing a drug usage guidelines program. Huber SL; Patry RA; Hudson HD; Godwin HN Hosp Formul; 1984 Aug; 19(8):664-8. PubMed ID: 10267390 [TBL] [Abstract][Full Text] [Related]
51. Developing a quick reference formulary. Huntzinger PE Mil Med; 2001 Oct; 166(10):881-3. PubMed ID: 11603239 [TBL] [Abstract][Full Text] [Related]
53. FDA action spurs change in groups' drug programs. Perry PA Hosp Mater Manage; 1989 Nov; 14(11):1, 13-4. PubMed ID: 10295911 [No Abstract] [Full Text] [Related]
54. Predetermined standards in drug use control. Lipman AG Hosp Formul; 1979 Sep; 14(9):864. PubMed ID: 10243911 [No Abstract] [Full Text] [Related]
55. Implementing an automatic fluoroquinolone therapeutic interchange program in a community hospital. Mioduch HJ Hosp Formul; 1992 Sep; 27(9):943-4, 947. PubMed ID: 10128743 [TBL] [Abstract][Full Text] [Related]
56. Rethinking the formulary system concept. Introduction. Zellmer WA Am J Hosp Pharm; 1986 Nov; 43(11):2829. PubMed ID: 3799621 [No Abstract] [Full Text] [Related]
57. Hospital pharmacists play a key role in drug product selection. McCausland W; Wallner J; Zellmer WA Med Mark Media; 1981 May; 16(5):43-6. PubMed ID: 10251528 [No Abstract] [Full Text] [Related]
58. The effects of differences in state drug product selection laws on pharmacists' substitution behavior. Carroll NV; Fincham JE; Cox FM Med Care; 1987 Nov; 25(11):1069-77. PubMed ID: 3695637 [TBL] [Abstract][Full Text] [Related]